Studies indicated that high levels of phosphorylated STAT5 enhance the resistance of CML cells to TKIs but also triggers BCR-ABL mutations by inducing the production of reactive oxygen species (ROS) responsible for DNA damage [57,58,59]. This evidence concerns the gene STAT5A and chronic myelogenous leukemia, BCR-ABL1 positive.